Squarepoint Ops LLC Aadi Bioscience, Inc. Transaction History
Squarepoint Ops LLC
- $59.6 Billion
- Q2 2024
A detailed history of Squarepoint Ops LLC transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 20,630 shares of AADI stock, worth $42,497. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,630Holding current value
$42,497% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding AADI
# of Institutions
68Shares Held
12MCall Options Held
9.4KPut Options Held
2.5K-
Avoro Capital Advisors LLC New York, NY2.85MShares$5.87 Million0.06% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA1.85MShares$3.81 Million2.91% of portfolio
-
Satter Management Co., L.P.1.63MShares$3.36 Million4.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA766KShares$1.58 Million0.0% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC526KShares$1.08 Million1.41% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $43.3M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...